NCM Houston: Updates to EPI2ME

Dr. Matt Parker is Associate Director, Clinical Bioinformatics at Oxford Nanopore Technologies and sits in  the customer workflows (EPI2ME) team. The customer workflows team produce bioinformatics analysis  workflows and platforms (EPI2ME) for the analysis of Oxford Nanopore sequencing data. As a health care  and professionals council registered clinical bioinformatician, Matt is interested in how we can apply Oxford  Nanopore sequencing to improve human health through better genomic diagnostics. Matt and his team are  focussed on developing medical device grade analysis workflows across infectious diseases, rare disease, and cancer that can be deployed on Oxford Nanopore devices and in the cloud to take Oxford Nanopore  sequencing reads and derive meaningful clinical interpretations